These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 20942634

  • 1. Latest developments in targeted therapy for hepatocellular carcinoma.
    Montella L, Addeo R, Caraglia M, Del Prete S.
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1635-46. PubMed ID: 20942634
    [Abstract] [Full Text] [Related]

  • 2. Molecular targeted therapy of advanced hepatocellular carcinoma beyond sorafenib.
    Yau T, Pang R, Chan P, Poon RT.
    Expert Opin Pharmacother; 2010 Sep; 11(13):2187-98. PubMed ID: 20707757
    [Abstract] [Full Text] [Related]

  • 3. Targeted therapy of hepatocellular carcinoma: present and future.
    Chan SL, Yeo W.
    J Gastroenterol Hepatol; 2012 May; 27(5):862-72. PubMed ID: 22369685
    [Abstract] [Full Text] [Related]

  • 4. Complete histologic response induced by sorafenib in advanced hepatocellular carcinoma: a case report.
    Curtit E, Thiery-Vuillemin A, Nguyen T, Heyd B, Pivot X, Di Martino V, Borg C.
    J Clin Oncol; 2011 Apr 20; 29(12):e330-2. PubMed ID: 21263091
    [No Abstract] [Full Text] [Related]

  • 5. Targeted therapy of hepatocellular cancer.
    Wysocki PJ.
    Expert Opin Investig Drugs; 2010 Feb 20; 19(2):265-74. PubMed ID: 20074016
    [Abstract] [Full Text] [Related]

  • 6. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
    Lang A, Graeven U.
    Zentralbl Chir; 2009 Jun 20; 134(3):189-92. PubMed ID: 19544236
    [No Abstract] [Full Text] [Related]

  • 7. Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.
    Kudo M, Ueshima K.
    Oncology; 2010 Jul 20; 78 Suppl 1():154-66. PubMed ID: 20616599
    [Abstract] [Full Text] [Related]

  • 8. Successful targeted therapies for hepatocellular carcinoma: are we really getting there?
    Zhu AX.
    Expert Rev Anticancer Ther; 2008 Apr 20; 8(4):499-505. PubMed ID: 18402516
    [No Abstract] [Full Text] [Related]

  • 9. [Hepatocellular carcinoma].
    Kondo S, Ueno H, Morizane C, Okusaka T.
    Gan To Kagaku Ryoho; 2010 Jul 20; 37(7):1219-23. PubMed ID: 20647702
    [Abstract] [Full Text] [Related]

  • 10. Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.
    O'Neil BH, Venook AP.
    Oncologist; 2007 Dec 20; 12(12):1425-32. PubMed ID: 18165619
    [Abstract] [Full Text] [Related]

  • 11. Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma.
    Kudo M.
    Dig Dis; 2011 Dec 20; 29(3):289-302. PubMed ID: 21829020
    [Abstract] [Full Text] [Related]

  • 12. Targeted therapies for hepatocellular carcinoma.
    Skelton MR, O'Neil B.
    Clin Adv Hematol Oncol; 2008 Mar 20; 6(3):209-18. PubMed ID: 18391920
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Emerging targeted strategies in advanced hepatocellular carcinoma.
    Finn RS.
    Semin Liver Dis; 2013 Feb 20; 33 Suppl 1():S11-9. PubMed ID: 23457035
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine kinase inhibitors to treat liver cancer.
    Huynh H.
    Expert Opin Emerg Drugs; 2010 Mar 20; 15(1):13-26. PubMed ID: 20128706
    [Abstract] [Full Text] [Related]

  • 17. Novel inhibitors in development for hepatocellular carcinoma.
    Wörns MA, Galle PR.
    Expert Opin Investig Drugs; 2010 May 20; 19(5):615-29. PubMed ID: 20374038
    [Abstract] [Full Text] [Related]

  • 18. Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma.
    Cheng AL, Shen YC, Zhu AX.
    Oncology; 2011 May 20; 81(5-6):372-80. PubMed ID: 22269894
    [Abstract] [Full Text] [Related]

  • 19. Molecular targeted therapies in hepatocellular carcinoma.
    Tanaka S, Arii S.
    Semin Oncol; 2012 Aug 20; 39(4):486-92. PubMed ID: 22846865
    [Abstract] [Full Text] [Related]

  • 20. Molecular pathogenesis and targeted therapy of hepatocellular carcinoma.
    Zender L, Kubicka S.
    Onkologie; 2008 Oct 20; 31(10):550-5. PubMed ID: 18854656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.